Condition: Metabolic Syndrome · Cardiovascular Diseases · Sponsor: Tian Zezhong
This study aims to evaluate the ameliorating effect of coenzyme Q10 supplementation on cardiovascular risk factors in high risk population for metabolic syndrome, including blood lipid metabolism, insulin resistance, blood pressure regulation, platelet function, endothelial function, cardiorespiratory fitness and muscle function.
This description comes directly from the study's public registry record.
yan yang · +86 20 8733 0687 · yangyan3@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| School of Public Health (Shenzhen), Sun Yat-sen University | Shenzhen, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06506630